# Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

> **NCT06250946** · PHASE2 · COMPLETED · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 235 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** HRS-7535;Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06250946
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-23
- **Primary completion:** 2025-01-22
- **Final completion:** 2025-01-22
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06250946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06250946, "Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06250946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*